CEACAM1 Antibodies

Santa Cruz Biotechnology delivers a wide array of CEACAM1 monoclonal antibodies for research focused on understanding this important protein. CEACAM1, a member of the carcinoembryonic antigen (CEA) family, plays a crucial role in cell adhesion, immune response modulation, and tumor progression. CEACAM1 monoclonal antibodies are suitable for various applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). CEACAM1 is significant in both normal physiological processes and pathological conditions, particularly in cancer biology, where it can influence tumor growth and metastasis. Its ability to interact with other cell surface proteins makes CEACAM1 a key player in cell signaling pathways and immune evasion mechanisms. Understanding CEACAM1 function is essential for developing targeted therapies and improving diagnostic strategies in oncology. CEACAM1 monoclonal antibodies enable precise detection and analysis of protein expression patterns across different tissue types. Researchers worldwide rely on Santa Cruz Biotechnology monoclonal antibodies to advance scientific understanding of CEACAM1's role in human health and disease.